Anti-Therapeutic Action: antifungal drug resistance

Pathogenic potential of polyextremotolerant fungi in a warming world

mycolabadmin

Certain fungi can survive extremely harsh conditions like extreme temperatures and dry environments, and many of these same species can cause infections in humans. As the planet warms due to climate change, these fungi are becoming better adapted to higher temperatures, which makes them more dangerous as human pathogens. Scientists are working to better understand these fungi and develop new treatments and vaccines to protect people from fungal infections.

Read More »

Global, Regional, and National Burden of Pulmonary Fungal Infections 1990–2021

mycolabadmin

This study analyzed the global impact of fungal lung infections from 1990 to 2021, finding that about 5.6 million people were affected in 2021 with significant mortality rates. The burden of these infections is particularly high in low- and middle-income countries and affects older individuals more severely. The researchers project that deaths from fungal lung infections will double by 2044, emphasizing the need for better prevention strategies, vaccines, and international cooperation to address this growing health challenge.

Read More »

The Burden of Neonatal Invasive Candidiasis in Low- and Middle-income Countries: A Systematic Review and Meta-analysis

mycolabadmin

This study examined fungal blood infections in newborns across low- and middle-income countries, analyzing data from nearly 11,000 cases. Researchers found these infections occur more frequently and have higher death rates in poorer countries compared to wealthy nations. They identified that most infections are caused by Candida fungus species, and many of these fungi have become resistant to fluconazole, the most commonly used treatment drug.

Read More »

John Perfect Shares Insights on Infectious Diseases, Antifungal Therapy, and Drug Resistance

mycolabadmin

Dr. John Perfect, a leading infectious disease expert, discusses his 48-year career studying fungal infections, particularly cryptococcal meningitis. He reflects on the dramatic transformation of HIV/AIDS from a fatal disease to a manageable chronic condition and emphasizes that antifungal resistance is less concerning than the underlying diseases that complicate treatment. Perfect advocates for developing more potent antifungal drugs that work faster, and discusses promising approaches like molecular diagnostics and immune-based therapies to improve patient outcomes.

Read More »

New insights toward personalized therapies for vulvovaginal candidiasis and vaginal co-infections

mycolabadmin

Vaginal yeast infections (vulvovaginal candidiasis) and bacterial vaginosis are very common conditions affecting millions of women worldwide. Current treatments often fail or lead to antibiotic resistance. This review explores new personalized approaches including zinc supplementation, specific probiotics, and immune-boosting therapies that are tailored to each woman’s unique vaginal environment to prevent recurring infections.

Read More »

Recognizing the Importance of Public Health Mycology

mycolabadmin

This editorial highlights how fungal infections are a growing but overlooked global health crisis, killing about 2.5 million people annually. The paper brings together seven research articles studying different fungal diseases, from lung infections to skin conditions, showing how these diseases spread differently in different populations and how resistance to antifungal medications is increasing. The authors emphasize that better testing, treatment access, and worldwide disease tracking are urgently needed, especially in poorer countries where the burden of fungal disease is highest.

Read More »
Scroll to Top